General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
High Potency APIs (HPAPIs)
... reach US$46.9 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Innovative HPAPIs, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach ... Read More
-
Aluminum Stearates
... CAGR of 6.2% over the analysis period 2023-2030. Polymer & Rubber End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$348.9 Million by the end of ... Read More
-
CBD Gummies
... CAGR of 28.7% over the analysis period 2023-2030. Low Concentration CBD Gummies, one of the segments analyzed in the report, is expected to record a 28.1% CAGR and reach US$32.4 Billion by the end of ... Read More
-
Nutraceutical Excipients
... at a CAGR of 6.1% over the analysis period 2023-2030. Dry Nutraceutical Excipients, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$5.1 Billion by the end ... Read More
-
Animal Blood Plasma Products and Derivatives
... the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Cell Culture Media Application, one of the segments analyzed in the report, is ... Read More
-
Oral Solid Dosage Forms (OSDF) and Pharma Excipients
... Excipients estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Polymers, one of the segments analyzed in ... Read More
-
Glucose, Dextrose, and Maltodextrin
... reach US$64.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
Marijuana Drying and Curing Equipment
... Million by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$49.9 Million While China is Forecast to Grow at 8.6% CAGR The Marijuana Drying and ... Read More
-
Lactoferrin
... 6.9% over the analysis period 2023-2030. Iron Absorption Function, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$161.1 Million by the end of the analysis period. ... Read More
-
CBD Nutraceuticals
... CAGR of 18.1% over the analysis period 2023-2030. CBD Tinctures, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$11.9 Billion by the end of the analysis ... Read More
-
Portugal Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Portugal) report will tell you the companies that have a declining financial ... Read More
-
India Pharmaceuticals and Medicine - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals and Medicine (India) report will tell you the ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
Potassium Iodide
... at a CAGR of 6.2% over the analysis period 2023-2030. X-Ray Contrast Media End-Use, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$627.6 Million by the ... Read More
-
Pharmerging
... of 9.8% over the analysis period 2023-2030. Pharmaceutical Pharmerging, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Cannabis Extract
... at a CAGR of 15.5% over the analysis period 2023-2030. Oils, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$34.1 Billion by the end of the ... Read More
-
Castor Oil and Derivatives
... 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Sebacic Acid, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$557.8 Million by the ... Read More
-
Zinc Stearates
... CAGR of 6.9% over the analysis period 2023-2030. Polymer & Rubber Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Iridium
... 5.3% over the analysis period 2023-2030. Automobile End-Use, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth ... Read More
-
Pharmaceutical Wholesaling in the UK - Industry Market Research Report
... hampered performance because it has lowered revenue generated from such medications. Increasingly stringent regulation has encouraged greater consumption of generic medicines and intensified downward pricing pressures. Regulatory and funding challenges threaten wholesalers, favouring the retail ... Read More
-
Medical Marijuana Dispensaries in the US - Industry Market Research Report
... Medical marijuana is most used for pain control, typically to ease chronic pain. Marijuana can additionally be used to manage nausea, anxiety, and weight loss. The legalization of marijuana for medical purposes and the growing ... Read More
-
Excipients in Pharmaceuticals: Global Markets to 2029
... product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new ... Read More
-
Asia Pacific Biopharma Excipients Market Size, Share & Trends Analysis Report By Product (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Specialty Biopharma Excipients), By Country, And Segment Forecasts, 2024 - 2030
... & Trends The Asia Pacific biopharma excipient market size is expected to reach USD 1.1 billion in 2030 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. Patent expiry of ... Read More
-
Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, Topical, Others), Product (Organic Chemicals, Inorganic Chemicals) – Industry Forecast 2032
... was valued at USD 9.27 billion in 2023 and is expected to rise from USD 10.02 billion in 2024 to USD 18.48 billion by 2032, with a compound annual growth rate (CAGR) of 7.03% during ... Read More
Research Assistance
